Progressive ganglion cell loss and optic nerve degeneration in DBA/2J mice is variable and asymmetric
- PMID: 17018142
- PMCID: PMC1621073
- DOI: 10.1186/1471-2202-7-66
Progressive ganglion cell loss and optic nerve degeneration in DBA/2J mice is variable and asymmetric
Abstract
Background: Glaucoma is a chronic neurodegenerative disease of the retina, characterized by the degeneration of axons in the optic nerve and retinal ganglion cell apoptosis. DBA/2J inbred mice develop chronic hereditary glaucoma and are an important model system to study the molecular mechanisms underlying this disease and novel therapeutic interventions designed to attenuate the loss of retinal ganglion cells. Although the genetics of this disease in these mice are well characterized, the etiology of its progression, particularly with respect to retinal degeneration, is not. We have used two separate labeling techniques, post-mortem DiI labeling of axons and ganglion cell-specific expression of the betaGeo reporter gene, to evaluate the time course of optic nerve degeneration and ganglion cell loss, respectively, in aging mice.
Results: Optic nerve degeneration, characterized by axon loss and gliosis is first apparent in mice between 8 and 9 months of age. Degeneration appears to follow a retrograde course with axons dying from their proximal ends toward the globe. Although nerve damage is typically bilateral, the progression of disease is asymmetric between the eyes of individual mice. Some nerves also exhibit focal preservation of tracts of axons generally in the nasal peripheral region. Ganglion cell loss, as a function of the loss of betaGeo expression, is evident in some mice between 8 and 10 months of age and is prevalent in the majority of mice older than 10.5 months. Most eyes display a uniform loss of ganglion cells throughout the retina, but many younger mice exhibit focal loss of cells in sectors extending from the optic nerve head to the retinal periphery. Similar to what we observe in the optic nerves, ganglion cell loss is often asymmetric between the eyes of the same animal.
Conclusion: A comparison of the data collected from the two cohorts of mice used for this study suggests that the initial site of damage in this disease is to the axons in the optic nerve, followed by the subsequent death of the ganglion cell soma.
Figures











Similar articles
-
Axons of retinal ganglion cells are insulted in the optic nerve early in DBA/2J glaucoma.J Cell Biol. 2007 Dec 31;179(7):1523-37. doi: 10.1083/jcb.200706181. Epub 2007 Dec 24. J Cell Biol. 2007. PMID: 18158332 Free PMC article.
-
Early astrocyte redistribution in the optic nerve precedes axonopathy in the DBA/2J mouse model of glaucoma.Exp Eye Res. 2016 Sep;150:22-33. doi: 10.1016/j.exer.2015.11.016. Epub 2015 Dec 2. Exp Eye Res. 2016. PMID: 26646560 Free PMC article.
-
Glial coverage in the optic nerve expands in proportion to optic axon loss in chronic mouse glaucoma.Exp Eye Res. 2016 Sep;150:34-43. doi: 10.1016/j.exer.2016.01.014. Epub 2016 Feb 3. Exp Eye Res. 2016. PMID: 26851485 Free PMC article.
-
Assessment of retinal ganglion cell damage in glaucomatous optic neuropathy: Axon transport, injury and soma loss.Exp Eye Res. 2015 Dec;141:111-24. doi: 10.1016/j.exer.2015.06.006. Epub 2015 Jun 9. Exp Eye Res. 2015. PMID: 26070986 Review.
-
Critical pathogenic events underlying progression of neurodegeneration in glaucoma.Prog Retin Eye Res. 2012 Nov;31(6):702-19. doi: 10.1016/j.preteyeres.2012.07.001. Epub 2012 Aug 1. Prog Retin Eye Res. 2012. PMID: 22871543 Free PMC article. Review.
Cited by
-
Functional protective effects of long-term memantine treatment in the DBA/2J mouse.Doc Ophthalmol. 2013 Jun;126(3):221-32. doi: 10.1007/s10633-013-9380-3. Epub 2013 Mar 22. Doc Ophthalmol. 2013. PMID: 23519764
-
Effects of glaucoma on Chrna6 expression in the retina.Curr Eye Res. 2013 Jan;38(1):150-7. doi: 10.3109/02713683.2012.724512. Epub 2012 Sep 24. Curr Eye Res. 2013. PMID: 23002780 Free PMC article.
-
Silencing of Fem1cR3 gene expression in the DBA/2J mouse precedes retinal ganglion cell death and is associated with histone deacetylase activity.Invest Ophthalmol Vis Sci. 2012 Mar 15;53(3):1428-35. doi: 10.1167/iovs.11-8872. Print 2012 Mar. Invest Ophthalmol Vis Sci. 2012. PMID: 22297488 Free PMC article.
-
Target-Derived Neurotrophic Factor Deprivation Puts Retinal Ganglion Cells on Death Row: Cold Hard Evidence and Caveats.Int J Mol Sci. 2019 Sep 3;20(17):4314. doi: 10.3390/ijms20174314. Int J Mol Sci. 2019. PMID: 31484425 Free PMC article. Review.
-
Mouse model of ocular hypertension with retinal ganglion cell degeneration.PLoS One. 2019 Jan 14;14(1):e0208713. doi: 10.1371/journal.pone.0208713. eCollection 2019. PLoS One. 2019. PMID: 30640920 Free PMC article.
References
-
- John SWM, Smith RS, Savinova OV, Hawes NL, Chang B, Turnbull D, Davisson M, Roderick TH, Heckenlively JR. Essential iris atrophy, pigment dispersion, and glaucoma in DBA/2J mice. Invest Ophthalmol Vis Sci. 1998;39:951–962. - PubMed
-
- Mo JS, Anderson MG, Gregory M, Smith RS, Savinova OV, Sereze DV, Ksander BR, Streilein JW, John SWM. By altering ocular immune privilege, bone marrow-derived cells pathogenetically contribute to DBA/2J pigmentary glaucoma. J Exp Med. 2003;197:1335–1344. doi: 10.1084/jem.20022041. - DOI - PMC - PubMed
-
- Libby RT, Anderson MG, Pang IH, Robinson Z, Savinova OV, Cosma IM, Snow A, Wilson LA, Smith RS, Clark AF, John SWM. Inherited glaucoma in DBA/2J mice: pertinent disease features for studying the neurodegeneration. Vis Neurosci. 2005;22:637–648. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical